Cleared Traditional

K843271 - SYSTEMATE CK-TOTAL - 67206

K843271 is the FDA 510(k) clearance for SYSTEMATE CK-TOTAL - 67206 by Em Diagnostic Systems, Inc.. It is a Class 2 Chemistry device (product code CGS) cleared through the Traditional 510(k) pathway after a 18-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1984
Decision
18d
Days
Class 2
Risk

K843271 is an FDA 510(k) clearance for the SYSTEMATE CK-TOTAL - 67206. Classified as Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes (product code CGS), Class II - Special Controls.

Submitted by Em Diagnostic Systems, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 7, 1984 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Em Diagnostic Systems, Inc. devices

Submission Details

510(k) Number K843271 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 20, 1984
Decision Date September 07, 1984
Days to Decision 18 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 88d · This submission: 18d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes

All 99
Devices cleared under the same product code (CGS) and FDA review panel - the closest regulatory comparables to K843271.
SYSTEMATE CK-MB(NAC-ACTIVATED) ITEM NO. 67205
K852483 · Em Diagnostic Systems, Inc. · Jul 1985
ISOENZYME TEST CK-MB
K850212 · Sclavo, Inc. · Feb 1985
TITAN GEL ISO DOT CPK PROCEDURE
K842755 · Helena Laboratories · Sep 1984
CREATINE KINASE ASSAY KIT NAC
K842508 · Diagnostic Chemicals, Ltd. (Usa) · Jul 1984
SIGMA PROCEDURE 47-UV
K842013 · Sigma Chemical Co. · Jun 1984
CREATINE KINASE MB REAGENT
K840783 · American Dade · Apr 1984